Clinical Trials Browser

Observational × Biliary Tract Neoplasms × pembrolizumab × Clear all

NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03695952 2025-01-28

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular